📊 A$95.3M raised across 12 deals | 4 sectors | Market sentiment: Mixed | Premium pricing trend notable
Major Capital Raisings
Syrah Resources Limited (SYR)
Placement + Entitlement
A$70.0M
Market Cap: $396M +2.7% ●
A$70.0M
Market Cap: $396M +2.7% ●
Structure: Institutional placement and 1:5.42 pro rata entitlement offer
Volume Interest: 0.32x (low)
Key Supporter: AustralianSuper committed to full entitlement
Volume Interest: 0.32x (low)
Key Supporter: AustralianSuper committed to full entitlement
Use of Funds: Vidalia operating costs, DOE loan reserves, general corporate expenses
Standout Metric: AustralianSuper sub-underwriting up to ~A$30M, strategic DOE partnership
Viridis Mining and Minerals Limited (VMM)
Premium Placement
AU$11.5M
Market Cap: $86M +12.99% ●
AU$11.5M
Market Cap: $86M +12.99% ●
Issue Price: AU$0.91 (13% premium to 10-day VWAP)
Volume Interest: 2.34x (high)
Status: Heavily oversubscribed
Volume Interest: 2.34x (high)
Status: Heavily oversubscribed
Use of Funds: Colossus Rare Earth Project development to FID
Standout Metric: AU$5M cornerstone from JGP Asset Management, government support secured
Strategic Investments & Smaller Rounds
Cambium Bio Limited (CMB)
Premium Placement
A$2.12M
Market Cap: $5.3M +39.39% ●
A$2.12M
Market Cap: $5.3M +39.39% ●
Issue Price: A$0.4637 (59.9% premium to last close)
Volume Interest: 11.69x (high)
Lead Investor: Da Jyun Capital (A$2.07M)
Volume Interest: 11.69x (high)
Lead Investor: Da Jyun Capital (A$2.07M)
Use of Funds: Phase 3 trials for Elate Ocular®
Standout Metric: 60% premium represents independent investor belief in Elate Ocular® intrinsic value
Codeifai Limited (CDE)
Placement
$2.35M
Market Cap: $12.3M -4.55% ●
$2.35M
Market Cap: $12.3M -4.55% ●
Issue Price: $0.02
Volume Interest: 1.3x (above average)
Special Terms: Exploring bonus option entitlement
Volume Interest: 1.3x (above average)
Special Terms: Exploring bonus option entitlement
Use of Funds: Business development, QuantumAI Secure platform commercialization
Standout Metric: Bonus option entitlement under consideration for existing shareholders
Debt & Alternative Financing
Jade Gas Holdings Ltd (JGH)
Director Loan
A$3.64M
Market Cap: $54M -8.57% ●
A$3.64M
Market Cap: $54M -8.57% ●
Terms: 8% interest, 24-month term, unsecured
Lender: Executive Director Joseph Burke
Volume Interest: 0.34x (low)
Lender: Executive Director Joseph Burke
Volume Interest: 0.34x (low)
Use of Funds: Red Lake Gas Field production activities
Standout Metric: Internal financing solution for operational continuity
Neurizon Therapeutics Limited (NUZ)
R&D Tax Rebate Loan
$1.5M
Market Cap: $83.7M -2.86% ●
$1.5M
Market Cap: $83.7M -2.86% ●
Terms: 17% interest rate, secured against 2025 R&D Tax Rebate
Provider: Radium Capital
Volume Interest: 1.47x (above average)
Provider: Radium Capital
Volume Interest: 1.47x (above average)
Use of Funds: Non-dilutive funding for pipeline advancement
Standout Metric: Non-dilutive structure preserves equity for future growth
Thanks for reading Capital Signal